The traveller and antimicrobial resistance: what's new and where are we headed?

被引：3
|
作者：
Riddle, Mark S. [1 ]
Ericsson, Charles D. [2 ]
Steffen, Robert [3 ,4 ]
机构：
[1] Univ Nevada, Reno Sch Med, Reno, NV 89557 USA
[2] McGovern Med Sch, Dept Internal Med, Houston, TX USA
[3] Univ Zurich, WHO Collaborating Ctr Travelers Hlth, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland
[4] Univ Texas Sch Publ Hlth Houston, Dept Epidemiol Human Genet & Environm Sci, Houston, TX USA
来源：
JOURNAL OF TRAVEL MEDICINE | 2021年 / 28卷 / 03期
关键词：
Antibiotic resistance; travellers diarrhoea; epidemiology; microbiome; military medicine; SPREAD;
D O I：
10.1093/jtm/taab053
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] What's new with PTH in osteoporosis: where are we and where are we headed?
    Rosen, CJ
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2004, 15 (05): : 229 - 233
  • [2] Chronic urticaria: What is new, where are we headed
    Ferrer, M.
    Kaplan, A. P.
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2007, 35 (02) : 57 - 61
  • [3] ASTM's bulk method: Where are we, where are we headed, where should we be headed?
    Stewart, IM
    ADVANCES IN ENVIRONMENTAL MEASUREMENT METHODS FOR ASBESTOS, 1999, 1342 : 122 - 126
  • [4] Inclusion, diversity, access, and equity in antimicrobial stewardship: where we are and where we are headed
    Cichon, Catherine J.
    Green, Evangeline C.
    Hilker, Eric
    Marcelin, Jasmine R.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2023, 36 (04) : 281 - 287
  • [5] Zebra chip, what we know and where are we headed
    Pierson, E. A.
    PHYTOPATHOLOGY, 2017, 107 (12) : 160 - 160
  • [6] CONSTRUCTION 4.0: WHAT WE KNOW AND WHERE WE ARE HEADED?
    Karmakar, Ankan
    Delhi, Venkata Santosh Kumar
    JOURNAL OF INFORMATION TECHNOLOGY IN CONSTRUCTION, 2021, 26 : 526 - 545
  • [7] Standards in the new millennium: Where we are, where we're headed
    Wise, AE
    Leibbrand, JA
    JOURNAL OF TEACHER EDUCATION, 2001, 52 (03) : 244 - 255
  • [8] PASSIVE IMMUNOTHERAPY FOR ALZHEIMER'S DISEASE: WHAT HAVE WE LEARNED, AND WHERE ARE WE HEADED?
    Aisen, P. S.
    Vellas, B.
    JOURNAL OF NUTRITION HEALTH & AGING, 2013, 17 (01): : 49 - 50
  • [9] Passive immunotherapy for Alzheimer’s disease: What have we learned, and where are we headed?
    P. S. Aisen
    B. Vellas
    The journal of nutrition, health & aging, 2013, 17 : 49 - 50
  • [10] Antimicrobial resistance dynamics of Listeria monocytogenes in France: where we are and what we need?
    Ed-Dra, Abdelaziz
    LANCET REGIONAL HEALTH-EUROPE, 2024, 37
12345